Dm. Pollock, Chronic studies on the interaction between nitric oxide and endothelin in cardiovascular and renal function, CLIN EXP PH, 26(3), 1999, pp. 258-261
Citations number
27
Categorie Soggetti
Pharmacology & Toxicology
Journal title
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
1. Chronic inhibition of nitric oxide synthase (NOS) results in a persisten
t hypertension, while chronic blockade of endothelin ETA receptors has litt
le effect on arterial pressure, These findings indicate that nitric oxide (
NO) plays a more significant role than ET-1 in the long-term maintenance of
arterial pressure,
2. Although endothelin (ET) appears to contribute to the hypertension in th
e early stages of NOS inhibition, blockade of either ETA or both ETA and ET
B receptors has only a minor effect on the hypertension beyond the initial
2 weeks of NOS inhibition.
3. Endothelin may play a role in vascular lesion development associated wit
h NOS inhibition, at least within the kidney, which may be related to angio
tensin II activity.
4. The processes involved in the hypertension associated with chronic NOS i
nhibition appear to be dynamic and may include an evolution of ET-1 action,
Variability in results from different laboratories may be related to genet
ic factors and choice of pharmacological agents.